Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.950.02%
QQQ
707.800.02%
BTC/USD
77072.301.8952%
DIA
527.75-
GLD
397.240.12%
TLT
81.810.07%

Virax Biolabs Group Ltd (VRAX) Stock Price, Quote, News & History

VRAXNASDAQ
Trade with Public
Trade with Public
$2.60
-0.22-7.8%
At close: Sep 1, 5:00 PM EST
$2.68
0.083.08%
After Hours: 4:21 PM EST
OverviewNewsEventsPrice TargetsFinancialsSentimentCompareStock Report

Key Statistics

Open
$2.82
Close
$2.60
Volume / Avg.
86.16K / 1.77M
Day Range
$2.56 - $2.84
52 Wk Range
2.50 - 21.75
Market Cap
$2.14M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
3.01%
Days to Cover
1

Recent Virax Biolabs Group Ltd News

Dow Gains 50 Points; Simulations Plus Earnings Top Views

Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares jumped 0.9% while health care fell 0.5%. Simulations Plus Inc beats earnings estimates, WD-40 Co and Jiuzi Holdings Inc see gains, eLong Power Holding Ltd and Virax Biolabs Group Ltd see losses. European shares mixed, Asian markets close mixed.
Avi Kapoor

US Stocks Edge Higher; Delta Air Lines Posts Upbeat Q2 Earnings

Dow Jones up 0.1%, Nasdaq up 0.07%, S&P 500 up 0.11%. Communication services up 0.9% and Health care down 0.8%. Delta Air Lines beats earnings.
Avi Kapoor

Gold Gains Over 1%; PepsiCo Shares Fall After Q2 Results

U.S. stocks higher, Dow gains over 150 points. NASDAQ up 0.84%, S&P 500 up 0.60%. Tech shares jump 1.3%, communication services down 1.7%. PepsiCo falls 5% on earnings miss. VRAX up 260%, FBRX up 42%, RKTO up 36%. AFJK drops 47%, GLOO down 19%, RXT down 23%. Oil down 0.9%, gold up 1.3%, silver up 3.6%, copper up 2.6%. European markets mostly higher, Asian markets mixed. U.S. jobless claims decline to 215,000.
Avi Kapoor

Why Did Virax Biolabs Stock Triple In One Session?

Virax Biolabs signs a Southeast Asia supply deal with Fosun Diagnostics, expanding ImmuneSelect sales across six regional markets.
Vandana Singh

Nasdaq Gains 100 Points; US Initial Jobless Claims Edge Lower

US stocks mixed, Nasdaq up 0.46% as Dow drops 0.06%. Tech shares surge 1.4%, consumer staples fall 1.7%. Initial jobless claims down to 215,000.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-4.62M
Investing Cash Flow (TTM)
-255.83K
Financing Cash Flow (TTM)
7.09M
Free Cash Flow (TTM)
-4.88M
Capital Expenditure (TTM)
-255.83K
Net Change in Cash (TTM)
2.21M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$3.78M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
90.25
PB Ratio (TTM)
0.30
Earnings Yield % (TTM)
-448.23%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$9.51

Company Debt

Total Debt
$28.48K
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$109.48K
Total Cash
$6.44M
Debt to Equity
0.05
Issuance of Debt (TTM)
-$109.48K
Repayment of Debt (TTM)
-$109.48K

Key Statistics

Open
$2.82
Close
$2.60
Volume / Avg.
86.16K / 1.77M
Day Range
$2.56 - $2.84
52 Wk Range
2.50 - 21.75
Market Cap
$2.14M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
3.01%
Days to Cover
1

About

Sector
Health Care
Industry
Health Care Providers & Services
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on pos...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Virax Biolabs Group (VRAX) stock?

A

You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Virax Biolabs Group (VRAX) competitors?

Q

What is the forecast, or price target, for Virax Biolabs Group (VRAX) stock?

A

Virax Biolabs Group has a consensus price target of $1.00.

Q

What is the current price for Virax Biolabs Group (VRAX)?

A

The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $2.68 last updated September 1, 2026 at 4:21 PM EDT.

Q

Does Virax Biolabs Group (VRAX) pay a dividend?

A

There are no upcoming dividends for Virax Biolabs Group.

Q

When is Virax Biolabs Group (NASDAQ:VRAX) reporting earnings?

A

Virax Biolabs Group does not have any upcoming earnings scheduled.

Q

Is Virax Biolabs Group (VRAX) going to split?

A

There is no upcoming split for Virax Biolabs Group.

Q

What sector and industry does Virax Biolabs Group (VRAX) operate in?

A

Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved